Overview
- 16 inspections across 16 sites are on record.
- 14 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-09-19.
At a glance
Inspections
16
Sites
16
Observations
14
Career since
Oct 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Covis Pharma GmBH | 19 Sep 2024 | Human Drugs | |
| William Whang M.D. | 23 Aug 2024 | Medical Devices & Rad Health | |
| David E. Bank, M.D. | 8 Aug 2024 | Medical Devices & Rad Health | |
| Pfizer, Inc. | 19 Jul 2024 | Biologics | |
| Adnan M. Dahdul, M.D. | 20 Jun 2024 | Biologics | On file |
Sites inspected
Covis Pharma GmBHWaltham, United States1 insp.
William Whang M.D.New York, United States1 insp.
David E. Bank, M.D.Mount Kisco, United States1 insp.
Pfizer, Inc.Groton, United States1 insp.
Adnan M. Dahdul, M.D.Springfield, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Matthew C Watson5 shared
Emily A Baldwin1 shared
Joy P Matthias1 shared
Michael Serrano1 shared
Tyanna N Hadley1 shared
Full investigator report
Get the verbatim findings behind Asia D Clark's 14 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site